The Stanford Amyloid Center is at the forefront of amyloidosis
treatment and research. We offer clinical trials and are dedicated to
learning more about the disease and advancing treatment options. Our
center provides an integrated, multidisciplinary approach to the care
of our patients.
Coordinated care and treatment of amyloidosis
Because amyloidosis affects multiple organs in the body, it is
important to have a comprehensive and coordinated treatment plan that
address all aspects of the disease.
At our center, we bring together experts across 10 specialties who
develop an individualized treatment plan for you.
Our team includes Stanford specialists in the following areas:
Do you know if you're at risk for heart disease? How healthy is your heart? In recognition of American Heart Month this February, stay heart healthy and celebrate your heart with us.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services
to refer and track patients, as well as the latest information and
news for physicians and office staff. For help with all referral needs
and questions, visit Referring Physicians.
HOW TO REFER
Fax patient records to 650-498-7452. Medical records include:
Recent labs (including but not limited to serum free light
chains, SPEP, UPEP)
Pathology reports from all biopsies
related to the amyloid diagnosis
Recent clinical notes from
any doctor involved with the amyloid diagnosis
echocardiogram report (if applicable).
For additional questions, please call Trisha Ulloa, RN at 650-725-6186 or email her